Emerging evidence has also emphasized the potential of pro-inflammatory cytokines such as interleukin-1β (IL- β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6), as biomarkers for AD [29]. This evidence concerns the gene TNF and Alzheimer disease.